CFDE Data Portal | Search UBXN7

	Label	Description
	UBXN7 associations Collection (Entity type)	Associations for UBXN7_associations
	UBXN7 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	UBXN7-AS1 associations Collection (Entity type)	Associations for UBXN7-AS1_associations
	UBXN7-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	UBXN7 Gene (Entity type)	ENSG00000163960 - UBX domain protein 7
	UBXN7-AS1 Gene (Entity type)	ENSG00000225822 - UBXN7 antisense RNA 1
	GSE145990 1 V 0 IBRUTINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 6 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 3 V 5 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE212231 GSE218491 SHP2 inhibition 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS

UBXN7 associations

Associations for UBXN7_associations

UBXN7 associations.tsv

A file from IDG as part of the Harmonizome project

UBXN7-AS1 associations

Associations for UBXN7-AS1_associations

UBXN7-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

UBXN7

ENSG00000163960 - UBX domain protein 7

UBXN7-AS1

ENSG00000225822 - UBXN7 antisense RNA 1

GSE145990 1 V 0 IBRUTINIB HUMAN UP

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 6 v 11 human up

A Gene Set from LINCS

GSE135350 3 V 5 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE212231 GSE218491 SHP2 inhibition 3 v 5 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.